DNA Script
Developer of an enzymatic DNA synthesis platform designed to facilitate genome-scale synthesis
Biotechnology
📍 Paris, France
Founded 2014
Current Valuation
$677M
as of 2021-Q4
PRIVATE
Developer of an enzymatic DNA synthesis platform designed to facilitate genome-scale synthesis
Company Profile
Last Round
Series C — $197M (Oct 2021)
Fundraising Status
Series C · $197M · 4y 8mo ago
privateTotal raised $299M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series C | $197M | Oct 2021 | — | $677M |
MedicalHealth CareBiotechnologyLife Science
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q4. Refreshed quarterly.